HebeCell is a company specializing in stem cell biology. It develops allogeneic natural killer (NK) cells indefinitely from induced pluripotent stem cells (iPS cells) by suspending them in a liquid solution within specially engineered bioreactors. The company aims to develop and commercialize cell-based therapeutics to treat incurable diseases and contribute to the fields of regenerative medicine and immuno-oncology.